Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (11-20 of 264) with videos related to

Pageof 27
Sort By:
Drugs|July 17, 2015
Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast CancerMarco Colleoni, Elisabetta Munzone
Breast (Edinburgh, Scotland)|August 8, 2015
Picking the optimal endocrine adjuvant treatment for pre-menopausal womenMarco Colleoni, Elisabetta Munzone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?Marco Colleoni, Richard D Gelber
The Oncologist|May 2, 2013
Debate: The biology of breast cancer in young women is uniqueMarco Colleoni, Carey K Anders
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for special types of breast cancerMarco Colleoni, Leila Russo, Silvia Dellapasqua
Cancer Treatment Reviews|June 4, 2013
The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: ready for prime time?Emilia Montagna, Giuseppe Cancello, Marco Colleoni
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2013
PET/CT and breast cancer subtypesLaura Gilardi, Marco Colleoni, Giovanni Paganelli
Hematology/Oncology Clinics of North America|August 7, 2013
Tailoring adjuvant treatments for the individual patient with luminal breast cancerElisabetta Munzone, Giuseppe Curigliano, Marco Colleoni
Breast (Edinburgh, Scotland)|November 17, 2009
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingMarco Colleoni, Giuseppe Viale, Aron Goldhirsch
Pageof 27

Showing results (11-20 of 264) with videos related to

Sort By:
Pageof 27
Drugs|July 17, 2015
Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast CancerMarco Colleoni, Elisabetta Munzone
Breast (Edinburgh, Scotland)|August 8, 2015
Picking the optimal endocrine adjuvant treatment for pre-menopausal womenMarco Colleoni, Elisabetta Munzone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?Marco Colleoni, Richard D Gelber
The Oncologist|May 2, 2013
Debate: The biology of breast cancer in young women is uniqueMarco Colleoni, Carey K Anders
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant therapies for special types of breast cancerMarco Colleoni, Leila Russo, Silvia Dellapasqua
Cancer Treatment Reviews|June 4, 2013
The aromatase inhibitors (plus ovarian function suppression) in premenopausal breast cancer patients: ready for prime time?Emilia Montagna, Giuseppe Cancello, Marco Colleoni
Ecancermedicalscience|June 18, 2015
Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive diseaseAron Goldhirsch, Marco Colleoni, Meredith Regan
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2013
PET/CT and breast cancer subtypesLaura Gilardi, Marco Colleoni, Giovanni Paganelli
Hematology/Oncology Clinics of North America|August 7, 2013
Tailoring adjuvant treatments for the individual patient with luminal breast cancerElisabetta Munzone, Giuseppe Curigliano, Marco Colleoni
Breast (Edinburgh, Scotland)|November 17, 2009
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingMarco Colleoni, Giuseppe Viale, Aron Goldhirsch
Pageof 27